160 related articles for article (PubMed ID: 24056146)
1. β-Ionone derived chalcones as potent antiproliferative agents.
Sharma V; Chaudhary A; Arora S; Saxena AK; Ishar MP
Eur J Med Chem; 2013 Nov; 69():310-5. PubMed ID: 24056146
[TBL] [Abstract][Full Text] [Related]
2. Chalcones with electron-withdrawing and electron-donating substituents: anticancer activity against TRAIL resistant cancer cells, structure-activity relationship analysis and regulation of apoptotic proteins.
Mai CW; Yaeghoobi M; Abd-Rahman N; Kang YB; Pichika MR
Eur J Med Chem; 2014 Apr; 77():378-87. PubMed ID: 24675137
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of novel β-carboline based chalcones with high cytotoxic activity against breast cancer cells.
Chauhan SS; Singh AK; Meena S; Lohani M; Singh A; Arya RK; Cheruvu SH; Sarkar J; Gayen JR; Datta D; Chauhan PM
Bioorg Med Chem Lett; 2014 Jul; 24(13):2820-4. PubMed ID: 24844196
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of novel isoxazolyl chalcones as potential anticancer agents.
Wan M; Xu L; Hua L; Li A; Li S; Lu W; Pang Y; Cao C; Liu X; Jiao P
Bioorg Chem; 2014 Jun; 54():38-43. PubMed ID: 24747188
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, structure activity relationship and mode of action of 3-substitutedphenyl-1-(2,2,8,8-tetramethyl-3,4,9,10-tetrahydro-2H,8H-pyrano[2,3-f]chromen-6-yl)-propenones as novel anticancer agents in human leukaemia HL-60 cells.
Murthy YL; Suhasini KP; Pathania AS; Bhushan S; Nagendra Sastry Y
Eur J Med Chem; 2013 Apr; 62():545-55. PubMed ID: 23419739
[TBL] [Abstract][Full Text] [Related]
6. β-Ionone derived apoptosis inducing endoperoxides; Discovery of potent leads for anticancer agents.
Sharma V; Chaudhry A; Chashoo G; Arora R; Arora S; Saxena AK; Ishar MP
Eur J Med Chem; 2014 Nov; 87():228-36. PubMed ID: 25259515
[TBL] [Abstract][Full Text] [Related]
7. Solid-phase synthesis of 2'-hydroxychalcones. Effects on cell growth inhibition, cell cycle and apoptosis of human tumor cell lines.
Neves MP; Cravo S; Lima RT; Vasconcelos MH; Nascimento MS; Silva AM; Pinto M; Cidade H; Corrêa AG
Bioorg Med Chem; 2012 Jan; 20(1):25-33. PubMed ID: 22177409
[TBL] [Abstract][Full Text] [Related]
8. Antimitotic and antiproliferative activities of chalcones: forward structure-activity relationship.
Boumendjel A; Boccard J; Carrupt PA; Nicolle E; Blanc M; Geze A; Choisnard L; Wouessidjewe D; Matera EL; Dumontet C
J Med Chem; 2008 Apr; 51(7):2307-10. PubMed ID: 18293907
[TBL] [Abstract][Full Text] [Related]
9. Syntheses and potential anti-prostate cancer activities of ionone-based chalcones.
Zhou J; Geng G; Batist G; Wu JH
Bioorg Med Chem Lett; 2009 Feb; 19(4):1183-6. PubMed ID: 19138519
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of thiophene analogues of chalcones.
Romagnoli R; Baraldi PG; Carrion MD; Cara CL; Cruz-Lopez O; Preti D; Tolomeo M; Grimaudo S; Di Cristina A; Zonta N; Balzarini J; Brancale A; Sarkar T; Hamel E
Bioorg Med Chem; 2008 May; 16(10):5367-76. PubMed ID: 18440234
[TBL] [Abstract][Full Text] [Related]
11. Apoptotic events induced by synthetic naphthylchalcones in human acute leukemia cell lines.
Maioral MF; Gaspar PC; Rosa Souza GR; Mascarello A; Chiaradia LD; Licínio MA; Moraes AC; Yunes RA; Nunes RJ; Santos-Silva MC
Biochimie; 2013 Apr; 95(4):866-74. PubMed ID: 23257665
[TBL] [Abstract][Full Text] [Related]
12. The products of the reaction between 6-amine-1,3-dimethyl uracil and bis-chalcones induce cytotoxicity with massive vacuolation in HeLa cervical cancer cell line.
Solano JD; González-Sánchez I; Cerbón MA; Guzmán Á; Martínez-Urbina MA; Vilchis-Reyes MA; Martínez-Zuñiga EC; Alvarado C; Quintero A; Díaz E
Eur J Med Chem; 2013 Feb; 60():350-9. PubMed ID: 23314048
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of β-ionone derived chalcones as potent antimicrobial agents.
Sharma V; Singh G; Kaur H; Saxena AK; Ishar MP
Bioorg Med Chem Lett; 2012 Oct; 22(20):6343-6. PubMed ID: 22999415
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and QSAR study of 2'-hydroxy-4'-alkoxy chalcone derivatives that exert cytotoxic activity by the mitochondrial apoptotic pathway.
Marquina S; Maldonado-Santiago M; Sánchez-Carranza JN; Antúnez-Mojica M; González-Maya L; Razo-Hernández RS; Alvarez L
Bioorg Med Chem; 2019 Jan; 27(1):43-54. PubMed ID: 30482548
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of indolyl chalcones as antitumor agents.
Kumar D; Kumar NM; Akamatsu K; Kusaka E; Harada H; Ito T
Bioorg Med Chem Lett; 2010 Jul; 20(13):3916-9. PubMed ID: 20627724
[TBL] [Abstract][Full Text] [Related]
16. Superior anticancer activity of halogenated chalcones and flavonols over the natural flavonol quercetin.
Dias TA; Duarte CL; Lima CF; Proença MF; Pereira-Wilson C
Eur J Med Chem; 2013 Jul; 65():500-10. PubMed ID: 23771043
[TBL] [Abstract][Full Text] [Related]
17. Antiproliferative activity and p53 upregulation effects of chalcones on human breast cancer cells.
Dos Santos MB; Bertholin Anselmo D; de Oliveira JG; Jardim-Perassi BV; Alves Monteiro D; Silva G; Gomes E; Lucia Fachin A; Marins M; de Campos Zuccari DAP; Octavio Regasini L
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1093-1099. PubMed ID: 31117836
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, anticancer and antioxidant activities of 2,4,5-trimethoxy chalcones and analogues from asaronaldehyde: structure-activity relationship.
Shenvi S; Kumar K; Hatti KS; Rijesh K; Diwakar L; Reddy GC
Eur J Med Chem; 2013 Apr; 62():435-42. PubMed ID: 23395966
[TBL] [Abstract][Full Text] [Related]
19. Antiproliferative activity of chalcones with basic functionalities.
Liu X; Go ML
Bioorg Med Chem; 2007 Nov; 15(22):7021-34. PubMed ID: 17804245
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of a series of podophyllotoxins derivatives as a class of potent antitubulin agents.
Liu Y; Wei D; Zhao Y; Cheng W; Lu Y; Ma Y; Li X; Han C; Wei Y; Cao H; Zhao C
Bioorg Med Chem; 2012 Nov; 20(21):6285-95. PubMed ID: 23022053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
